Do you want to read an article? Please log in or register.
Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins
Retinal DiseasesSurgery and Intervention
COMMENTED
Related content
RECOMMENDED
Retinal Diseases
Constriction of Retinal Venules to Endothelin-1: Obligatory Roles of ETA Receptors, Extracellular Calcium Entry, and Rho Kinase
Invest Ophthalmol Vis Sci.
Chen YL, Ren Y, Xu W, Rosa RH Jr, Kuo L, Hein TW
doi: 10.1167/iovs.18-25369.
Glaucoma and Ocular PressureOcular OncologyRetinal Diseases
Retinal venous pressure: the role of endothelin
EPMA J.
Flammer J, Konieczka K
doi: 10.1186/s13167-015-0043-1.
Macular DiseasesRetinal DiseasesFurther Publications
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL, Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group.
doi: 10.1001/jamaophthalmol.2021.4395
Retinal Diseases
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion
JAMA Ophthalmol.
Babiuch AS, Han M, Conti FF, Wai K, Silva FQ, Singh RP
doi: 10.1001/jamaophthalmol.
Macular DiseasesRetinal Diseases
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial
Ophthalmol Retina.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO, Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group.
doi: 10.1016/j.oret.2019.12.019.
Retinal Diseases
Intraocular Pressure Changes and VEGF Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry
Ophthalmol Retina.
Gabrielle PH, Nguyen V, Wolff B, Essex R, Young S, Hunt A, Gemmy Cheung CM, Arnold JJ, Barthelmes D, Creuzot-Garcher C, Gillies M, Fight Retinal Blindness! Study Group.
doi: 10.1016/j.oret.2020.06.020.
Retinal Diseases
Evaluation of retinal nonperfusion in branch retinal vein occlusion using wide-field optical coherence tomography angiography
Acta Ophthalmol.
Shiraki A, Sakimoto S, Tsuboi K, Wakabayashi T, Hara C, Fukushima Y, Sayanagi K, Nishida K, Sakaguchi H, Nishida K
doi: 10.1111/aos.14087.
Retinal Diseases
Retinal Nonperfusion in the Posterior Pole Is Associated With Increased Risk of Neovascularization in Central Retinal Vein Occlusion
Am J Ophthalmol.
Nicholson L, Vazquez-Alfageme C, Patrao NV, Triantafyllopolou I, Bainbridge JW, Hykin PG, Sivaprasad S
doi: 10.1016/j.ajo.2017.07.015.
COMMENTED
Retinal DiseasesFurther Publications
Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
Sci Rep
Lee J, Choe HR, Park SH, Do Han K, Kim DK, Joo KW, Kim YS, Lee EK, Park UC, Yu HG, Lee H, Kim YC, Oh BL
doi: 10.1038/s41598-021-90765-8